Akebia Therapeutics, Inc. (AKBA)
0.9188
+0.04
(+4.58%)
USD |
NASDAQ |
Aug 31, 16:00
0.9189
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Long Term Debt (Quarterly) : 209.81M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 209.81M |
| March 31, 2026 | 215.79M |
| December 31, 2025 | 212.75M |
| September 30, 2025 | 208.36M |
| June 30, 2025 | 204.93M |
| March 31, 2025 | 200.66M |
| December 31, 2024 | 189.25M |
| September 30, 2024 | 185.84M |
| June 30, 2024 | 99.44M |
| March 31, 2024 | 93.27M |
| December 31, 2023 | 99.69M |
| September 30, 2023 | 108.90M |
| June 30, 2023 | 110.51M |
| March 31, 2023 | 134.77M |
| December 31, 2022 | 152.52M |
| September 30, 2022 | 154.87M |
| June 30, 2022 | 186.63M |
| March 31, 2022 | 185.52M |
| December 31, 2021 | 184.32M |
| September 30, 2021 | 168.62M |
| June 30, 2021 | 167.75M |
| March 31, 2021 | 166.72M |
| December 31, 2020 | 121.00M |
| September 30, 2020 | 100.10M |
| June 30, 2020 | 101.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 102.28M |
| December 31, 2019 | 103.33M |
| September 30, 2019 | 28.81M |
| June 30, 2019 | 30.07M |
| March 31, 2019 | 31.30M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.014M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.014M |
| September 30, 2015 | 0.002M |
| June 30, 2015 | 0.004M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0103M |
| March 31, 2014 | 0.0113M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 586.70M |
| Exelixis, Inc. | 165.93M |
| ADMA Biologics, Inc. | 202.66M |
| Arcutis Biotherapeutics, Inc. | 114.14M |
| Relay Therapeutics, Inc. | 26.64M |